Enliven Therapeutics, Inc. (ELVN)
16.86
-1.91
(-10.18%)
USD |
NASDAQ |
Dec 12, 16:00
16.81
-0.05
(-0.30%)
After-Hours: 20:00
Enliven Therapeutics Market Cap: 1.001B for Dec. 12, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| CEL-SCI Corp. | 19.30M |
| AIM ImmunoTech, Inc. | 1.047M |
| IGC Pharma, Inc. | 32.29M |
| NovaBay Pharmaceuticals, Inc. | 352.83M |
| Protalix Biotherapeutics, Inc. | 143.95M |
Market Cap Related Metrics
| Price to Book Value | 2.102 |
| Price | 16.86 |
| Earnings Yield | -10.95% |